BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28669363)

  • 1. The Effect of Adding Comorbidities to Current Centers for Disease Control and Prevention Central-Line-Associated Bloodstream Infection Risk-Adjustment Methodology.
    Jackson SS; Leekha S; Magder LS; Pineles L; Anderson DJ; Trick WE; Woeltje KF; Kaye KS; Stafford K; Thom K; Lowe TJ; Harris AD
    Infect Control Hosp Epidemiol; 2017 Sep; 38(9):1019-1024. PubMed ID: 28669363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central-Line-Associated Bloodstream Infections in Québec Intensive Care Units: Results from the Provincial Healthcare-Associated Infections Surveillance Program (SPIN).
    Li L; Fortin E; Tremblay C; Ngenda-Muadi M; Quach C;
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1186-94. PubMed ID: 27430754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of multiple concurrent central venous catheters on central line-associated bloodstream infections.
    Concannon C; van Wijngaarden E; Stevens V; Dumyati G
    Infect Control Hosp Epidemiol; 2014 Sep; 35(9):1140-6. PubMed ID: 25111922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
    Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central line-associated bloodstream infections in non-ICU inpatient wards: a 2-year analysis.
    Rhee Y; Heung M; Chen B; Chenoweth CE
    Infect Control Hosp Epidemiol; 2015 Apr; 36(4):424-30. PubMed ID: 25782897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for central-line-associated bloodstream infections: a focus on comorbid conditions.
    Pepin CS; Thom KA; Sorkin JD; Leekha S; Masnick M; Preas MA; Pineles L; Harris AD
    Infect Control Hosp Epidemiol; 2015 Apr; 36(4):479-81. PubMed ID: 25782906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The descriptive epidemiology of central line-associated bloodstream infection among patients in non-intensive care unit settings.
    Tedja R; Gordon SM; Fatica C; Fraser TG
    Infect Control Hosp Epidemiol; 2014 Feb; 35(2):164-8. PubMed ID: 24442079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving Risk Adjustment Above Current Centers for Disease Control and Prevention Methodology Using Electronically Available Comorbid Conditions.
    Jackson SS; Leekha S; Pineles L; Magder LS; Thom KA; Wang Y; Harris AD
    Infect Control Hosp Epidemiol; 2016 Oct; 37(10):1173-8. PubMed ID: 27418295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central line-associated bloodstream infection surveillance outside the intensive care unit: a multicenter survey.
    Son CH; Daniels TL; Eagan JA; Edmond MB; Fishman NO; Fraser TG; Kamboj M; Maragakis LL; Mehta SA; Perl TM; Phillips MS; Price CS; Talbot TR; Wilson SJ; Sepkowitz KA
    Infect Control Hosp Epidemiol; 2012 Sep; 33(9):869-74. PubMed ID: 22869259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLABSI Risk Factors in the NICU: Potential for Prevention: A PICNIC Study.
    Dahan M; O'Donnell S; Hebert J; Gonzales M; Lee B; Chandran AU; Woolsey S; Escoredo S; Chinnery H; Quach C
    Infect Control Hosp Epidemiol; 2016 Dec; 37(12):1446-1452. PubMed ID: 27609629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electronically Available Comorbidities Should Be Used in Surgical Site Infection Risk Adjustment.
    Jackson SS; Leekha S; Magder LS; Pineles L; Anderson DJ; Trick WE; Woeltje KF; Kaye KS; Lowe TJ; Harris AD
    Clin Infect Dis; 2017 Sep; 65(5):803-810. PubMed ID: 28481976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statewide validation of hospital-reported central line-associated bloodstream infections: Oregon, 2009.
    Oh JY; Cunningham MC; Beldavs ZG; Tujo J; Moore SW; Thomas AR; Cieslak PR
    Infect Control Hosp Epidemiol; 2012 May; 33(5):439-45. PubMed ID: 22476268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central Line-Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National Study.
    Furuya EY; Dick AW; Herzig CT; Pogorzelska-Maziarz M; Larson EL; Stone PW
    Infect Control Hosp Epidemiol; 2016 Jul; 37(7):805-10. PubMed ID: 27052993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prospective, Holistic, Multicenter Approach to Tracking and Understanding Bloodstream Infections in Pediatric Hematology-Oncology Patients.
    Gaur AH; Bundy DG; Werner EJ; Hord JD; Miller MR; Tang L; Lawlor JP; Billett AL;
    Infect Control Hosp Epidemiol; 2017 Jun; 38(6):690-696. PubMed ID: 28399945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of intensive care unit-acquired central line-associated bloodstream infection on in-hospital mortality: A single-center risk-adjusted analysis.
    Wong SW; Gantner D; McGloughlin S; Leong T; Worth LJ; Klintworth G; Scheinkestel C; Pilcher D; Cheng AC; Udy AA
    Am J Infect Control; 2016 May; 44(5):587-92. PubMed ID: 26874406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of 2015 NHSN Catheter-associated Urinary Tract Infection (CAUTI) Definition Change on Central Line-associated Bloodstream Infection (CLABSI) Rates and CLABSI Prevention Efforts at an Academic Medical Center.
    Advani SD; Lee RA; Long M; Schmitz M; Camins BC
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):878-880. PubMed ID: 29665877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year surveillance of central line-associated bloodstream infections in South Korea: Surveillance not enough, action needed.
    Kim EJ; Kang SY; Kwak YG; Kim SR; Shin MJ; Yoo HM; Han SH; Kim DW; Choi YH;
    Am J Infect Control; 2020 Mar; 48(3):285-289. PubMed ID: 31493935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradicating central line-associated bloodstream infections statewide: the Hawaii experience.
    Lin DM; Weeks K; Bauer L; Combes JR; George CT; Goeschel CA; Lubomski LH; Mathews SC; Sawyer MD; Thompson DA; Watson SR; Winters BD; Marsteller JA; Berenholtz SM; Pronovost PJ; Pham JC
    Am J Med Qual; 2012; 27(2):124-9. PubMed ID: 21918016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.